Latest news for Newtopia (OTC:NEWUF) Stock

Newtopia Inc is a technology-enabled habit change company that delivers disease prevention solutions by leveraging genetic testing, and social and behavioral science to help individuals prevent chronic disease and reduce costs for health insurers.

News

Penny Stocks

Health Care

Markets

General

NEWUF

TSXV:NEWU

Focusing on Disease Prevention Can Benefit Individuals and Health Insurers - A New Approach to Healthcare

Newtopia Inc

Craig-Hallum analyst Jason Kreyer initiates coverage on Nextdoor Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KIND#NYSE">KIND</a>) with a Buy rating and announces Price Target of $4.

Price Target

Initiation

Analyst Ratings

KIND

Craig-Hallum Initiates Coverage On Nextdoor Holdings with Buy Rating, Announces Price Target of $4

Canaccord Genuity analyst Edward Nash maintains Corcept Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORT#NASDAQ">CORT</a>) with a Buy and raises the price target from $78 to $130.

CORT

Canaccord Genuity Maintains Buy on Corcept Therapeutics, Raises Price Target to $130

Guidance

Southwest Airlines COO Says Expect Current Demand Strength To Continue Into 2025

Southwest Airlines CEO Says While Boeing Still Have Much Work To Do, They Appear To Be On A Good Path And We Are Feeling More Optimistic; Believe Boeing Is On Pace To Exceed 38 Jets For The Carrier This Year; Experiencing Above Normal Unit Cost Inflation, Most Notably In Market Driven Wage Rates, Airport Costs

Mizuho analyst Vijay Rakesh reiterates Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Outperform and maintains $515 price target.

Reiteration

TSLA

Mizuho Reiterates Outperform on Tesla, Maintains $515 Price Target

<a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43299857/czech-central-bank-considering-5-bitcoin-reserve">The Czech National Bank</a> is exploring a potential expansion of its investment portfolio, as global institutions, such as the Norwegian sovereign wealth fund, show increasing exposure to assets like Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).
What Happened: The CNB&#8217;s Bank Board, during its Thursday meeting, <a href="https://www.cnb.cz/en/cnb-news/press-releases/CNB-to-assess-options-for-broadening-investment-to-include-other-asset-classes/">approved</a> an analysis into broadening its international reserves.
This decision follows two years of increasing diversification efforts and was propelled by a proposal from Governor Aleš Michl.
The aim is to assess the viability and benefits of incorporating new asset classes into their reserves, considering diversification and returns.
The analysis is underway and no immediate changes are anticipated. 
Once completed, the Bank Board will deliberate on any further actions. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43344908/bitcoin-will-not-be-considered-for-central-bank-reserves-ecb-president-christine-lagarde-says">&#8216;Bitcoin Will Not Be Considered For Central Bank Reserves,&#8217; ECB President Christine Lagarde Says</a>
Why It Matters: This move by the Czech central bank mirrors a broader trend of institutional funds subtly embracing assets like Bitcoin.
Notably, the Norwegian sovereign wealth fund (NBIM) has also seen significant growth in its Bitcoin holdings, albeit indirectly.
<a href="https://x.com/VetleLunde/status/1884551445590020106">According</a> to Vetle Lunde, Head of Research at K33, the NBIM now holds 3,821 BTC.
This signifies a substantial increase of 1,375 BTC since June 30, 2024, and a 2,314 BTC jump year-on-year. 
Its BTC holdings have grown by 153% compared to the end of 2023, underscoring the rapid maturation of Bitcoin as an <a href="https://www.benzinga.com/news/events/24/12/42437939/bitcoin-etfs-spark-institutional-interest-the-doors-have-been-blown-off-superstate-ceo-says">investment asset</a>.
Lunde clarified that the NBIM&#8217;s Bitcoin exposure isn&#8217;t a result of a deliberate direct purchase. 
It is rather an outcome of rule-based sector weighting, where companies that have exposure to Bitcoin have grown in value. 
Lunde added that increased NBIM holdings in companies like Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) and Metaplanet highlight this indirect trend.
He further noted that the per capita indirect exposure to Bitcoin in Norway via the NBIM translates to 68,837 sats (approximately $64) per person by the end of 2024. 
The financial impact of the NBIM's indirect Bitcoin exposure has skyrocketed from $23 million in 2020 to a substantial $356 million in 2024.
This comes as Bitcoin&#8217;s growth is reaching more of the traditional institutions through sector weighted strategies, whether intentionally or not.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43341558/bitcoin-ethereum-dogecoin-litecoin-are-the-most-popular-cryptos-for-online-casinos">Bitcoin, Ethereum, Dogecoin, Litecoin Are The Most Popular Cryptos For Online Casinos</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

RIOT

Institutional Bitcoin Buyer Boom: Czech National Bank Approves Reserve Proposal, Norway's Sovereign Wealth Fund Increases Exposure

Mizuho analyst Brett Linzey downgrades Lennox Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) from Outperform to Neutral and lowers the price target from $675 to $625.

Downgrades

Mizuho Downgrades Lennox Intl to Neutral, Lowers Price Target to $625

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) analysts highlighted a confirmation of the low-cost vehicle in 2025, unsupervised FSD and updates on Optimus Bot as the key takeaways from the company's <a href="https://www.benzinga.com/news/earnings/25/01/43321103/tesla-q4-earnings-highlights-revenue-miss-eps-miss-ev-updates-automaker-says-2025-will-be-a-seminal-year">fourth-quarter financial results.</a>
The Tesla Analysts: Bank of America analyst John Murphy reiterated a Neutral rating on Tesla with a $490 price target.
Goldman Sachs analyst Mark Delaney maintained a Neutral rating with a $345 price target.
Needham analyst Chris Pierce reiterated a Hold rating with no price target.
RBC Capital analyst Tom Narayan maintained an Outperform rating with a $440 price target.
Cantor Fitzgerald analyst Andres Sheppard maintained a Neutral rating and raised the price target from $365 to $425.
Piper Sandler analyst Alexander Potter maintained an Overweight rating with a $500 price target.
Stifel analyst Stephen Gengaro reiterated a Buy rating with a $492 price target.
Morgan Stanley analyst Adam Jonas maintained an Overweight rating with a $430 price target.
Read Also: <a href="https://www.benzinga.com/news/global/25/01/43251316/tesla-faces-boycott-call-in-poland-over-musks-wwii-comments">Tesla Faces Boycott Call In Poland Over Musk&#8217;s WWII Comments: &#8216;No Normal Pole Should Buy&#8217;</a>
Bank of America on TSLA: A mark-to-market benefit on the company's Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) investment helped cushion the company's gross margins, Murphy said in a new investment note.
"Excluding this gain, 4Q:24 results were materially weaker than our forecast," Murphy said.
The analyst said the new product launches being on-track and the robotaxi are positives, while concerns about volume, lower pricing, tariffs and the "Optimus distraction" are headwinds for the company.
"1Q:25 results will be adversely impacted by several weeks of lost Model Y production as TSLA shifting all of its factories to the new Model Y. This will weigh on revenues and gross margin. We roughly estimate TSLA will lose 100k vehicles of production from this changeover."
Goldman Sachs on TSLA: After reporting profitability below consensus estimates, Delaney said margins and FSD progress will likely be the key debates.
The analyst said strong energy profits and the non-cash gains on Bitcoin, estimated at 17 cents per share, weren't enough to offset weakness on gross margins.
"The automotive non-GAAP gross margin excluding regulatory credits declined to 13.6% in 4Q24 from 17.1% in 3Q24, below our 15.0% estimate and StreetAccounts consensus at ~16%," Delaney said.
The analyst said the quarterly results had something for bulls and bears. The negatives were profitability, earnings per share weakness, margins and the downtime for the Model Y transition.
"Positively, Tesla continue to expect to introduce a new lower cost model with production planned to start later in 1H25, and Tesla commented that it expects to start a robotaxi operation in Austin this June."
Delaney said FSD v13 is "very good," but Tesla needs to show more progress for it to become an eyes-off product.
"While we continue to see Tesla as a leader in autonomous technology, our base case remains that it will take the company longer to reach its AV goals than it targets."
Needham on TSLA: Telsa could struggle to match supply and demand, Pierce said in a new investor note.
The analyst said Tesla is playing catch-up in autonomous driving until it can unlock the full fleet of vehicles currently on the road.
Pierce said autonomous and robotics are "shouldering an even heavier load" for Tesla's growth story. Tesla's comments on Optimus Bot production levels were likely well received by bulls, Pierce said.
"ASPs are still fuzzy, and production cadence slippage wouldn't be overly surprising, but we expect bulls to welcome any TSLA Robotics disclosures," Pierce said.
The analyst said Tesla's confirmation of a low-priced vehicle could expand the company's total addressable market.
"Between this potential vehicle and the updated Model Y we see the potential for TSLA to refresh their vehicle lineup for the first time in years."
RBC Capital on TSLA: News on a low-cost vehicle, FSD, robotaxi and Optimus show that the "moonshots getting real," Narayan said in a new investor note.
The analyst said confirmation of the low-cost vehicle could be one of the most important items from the earnings report.
"We think some investors thought this would be withdrawn," Narayan said.
The analyst forecasts 2025 delivery growth of 14% helped by the affordable vehicle models set to be introduced.
Cantor Fitzgerald on TSLA: Tesla's announcement on unsupervised FSD, Optimus Bot and the confirmation of the lower-cost model in 2025 see Sheppard updating estimates and raising the price target in a new note.
"We are increasing our PT to $425 as we incorporate revenues from Unsupervised FSD starting in 2H25, and from Optimus starting 2H26, to our model, driven by higher energy generation and storage revenue estimates in FY25 and FY26," Sheppard said.
With the price target increase, Sheppard said there are key risks for Tesla remaining. Risks include Chinese automotive competition, regulatory approval for FSD and robotaxi, the removal of the EV tax credit and a slowdown in EV demand.
Piper Sandler on TSLA: Gross margins and lower average selling prices were misses in Tesla's fourth quarter, Potter said in a new investor note.
"Q4 results weren't great, but who cares? Elon has never sounded so bullish," Potter said of Tesla CEO Elon Musk.
The analyst said Tesla committed to new products and vehicle growth in 2025, along with bullish commentary on FSD software.
"It's true, Elon Musk's predictions re: FSD timing have been historically inaccurate…but to us, this time it feels different; peers (and investors) should not dismiss this."
Potter said solving FSD could be the first step of "commercializing real-world AI," which would open up new valuation scenarios for Tesla.
Stifel on TSLA: Fourth-quarter results are neutral for Tesla stock, Gengaro said in a new note.
The analyst said negatives in the report were revenue, gross margins and profit per vehicle sold. The positives were lower cost of goods per vehicle, strong 2025 expectations for vehicle growth, strong guidance for energy storage and progress on FSD/robotaxi.
"We reiterate our belief that TSLA remains very well positioned, and FSD and Robotaxi will be critical value drivers," Gengaro said.
Gengaro said FSD and robotaxi initiatives are "critical to the story."
The analyst said the removal of the $7,500 tax credit will hurt Tesla margins, but be a "bigger problem" for Tesla's competition.
"We believe that CEO Elon Musk's support for the President and involvement in the administration likely creates and easier path to FSD and Robotaxi."
Morgan Stanley on TSLA: A vague outlook and a miss on weaker prices have Jonas asking if Tesla is a car company with shares trading higher after the earnings report.
"4Q results were mostly disappointing, but not particularly narrative changing," Jonas said.
While Tesla said it expected a "return to growth" for vehicle delivery in 2025, Jonas said there was not a mention of Musk's previous guidance of 20% to 30% volume growth.
"Tesla's 4Q results are emblematic of a company in the transition from an automotive ‘pure play' to a highly diversified play on AI and robotics."
TSLA Price Action: Tesla stock is up 3.56% to $402.91 Thursday at publication versus a 52-week trading range of $138.80 to $488.54.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/43327268/tesla-expects-50-surge-in-energy-storage-deployments-for-2025-after-segment-revenue-doubles-in-q4">Tesla Expects 50% Surge In Energy Storage Deployments For 2025 After Segment Revenue Doubles In Q4</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Trading Ideas

Tesla Analysts Highlight FSD, Robotaxis, New Vehicles For Growth: 'Elon Has Never Sounded So Bullish'

Southwest Airlines CEO Says Pleased With The Work Boeing Is Doing

Oppenheimer analyst Jason Helfstein maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) with a Outperform and raises the price target from $215 to $225.

GOOG

GOOGL

Oppenheimer Maintains Outperform on Alphabet, Raises Price Target to $225

Oppenheimer analyst Jeff Jones initiates coverage on Alumis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALMS#NASDAQ">ALMS</a>) with a Outperform rating and announces Price Target of $32.

ALMS

Oppenheimer Initiates Coverage On Alumis with Outperform Rating, Announces Price Target of $32

In the current session, the stock is trading at $91.41, after a 2.69% increase. Over the past month, Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) stock increased by 4.67%, and in the past year, by 5.70%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1738259126_0.png" alt="Past Year Chart" />

<h3>Evaluating Micron Technology P/E in Comparison to Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 69.01 in the Semiconductors &amp; Semiconductor Equipment industry, Micron Technology Inc. has a lower P/E ratio of 25.5. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1738259126_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

P/E Ratio Insights for Micron Technology

CTSH

Live On CNBC, Segment Titled Josh's Best Stocks: Acenture, Gartner, Cognizant Technology Solutions; Shares See Volume To The Upside

Oppenheimer analyst Brian Schwartz maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Outperform and raises the price target from $1150 to $1200.

Oppenheimer Maintains Outperform on ServiceNow, Raises Price Target to $1200

Oppenheimer analyst Jason Helfstein maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Outperform and raises the price target from $650 to $800.

Oppenheimer Maintains Outperform on Meta Platforms, Raises Price Target to $800

Legal

FLUT

Flutter Entertainment And Aviator Agree On A Long-Term Commercial Partnership; Flutter Says As Part Of Deal Both Parties Have Agreed To Settle Their Outstanding Legal Dispute

B of A Securities analyst Mark McLaughlin maintains Raymond James Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) with a Buy and raises the price target from $198 to $201.

B of A Securities Maintains Buy on Raymond James Finl, Raises Price Target to $201

B of A Securities analyst Ken Hoexter maintains C.H. Robinson Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) with a Buy and lowers the price target from $130 to $122.

CHRW

B of A Securities Maintains Buy on C.H. Robinson Worldwide, Lowers Price Target to $122

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Industrials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UBER</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$69.00</td>
<td>$41.8K</td>
<td>4.8K</td>
<td>2.3K</td>
</tr>
<tr>
<td>NXT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$50.00</td>
<td>$40.8K</td>
<td>0</td>
<td>957</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$175.00</td>
<td>$51.1K</td>
<td>4.8K</td>
<td>579</td>
</tr>
<tr>
<td>LUNR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/07/25</td>
<td>$24.00</td>
<td>$61.0K</td>
<td>91</td>
<td>571</td>
</tr>
<tr>
<td>TTEK</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$44.00</td>
<td>$101.0K</td>
<td>440</td>
<td>425</td>
</tr>
<tr>
<td>UPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$115.00</td>
<td>$144.0K</td>
<td>1.5K</td>
<td>281</td>
</tr>
<tr>
<td>UPWK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$15.00</td>
<td>$62.5K</td>
<td>2.6K</td>
<td>250</td>
</tr>
<tr>
<td>UNP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$230.00</td>
<td>$25.7K</td>
<td>626</td>
<td>244</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$387.50</td>
<td>$55.4K</td>
<td>14</td>
<td>207</td>
</tr>
<tr>
<td>SMR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/07/25</td>
<td>$20.00</td>
<td>$41.9K</td>
<td>153</td>
<td>147</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding UBER (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), we observe a put option sweep with bullish sentiment. It expires in 1 day(s) on January 31, 2025. Parties traded 123 contract(s) at a $69.00 strike. This particular put needed to be split into 35 different trades to become filled. The total cost received by the writing party (or parties) was $41.8K, with a price of $340.0 per contract. There were 4873 open contracts at this strike prior to today, and today 2330 contract(s) were bought and sold. 
• For NXT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>), we notice a put option sweep that happens to be bearish, expiring in 197 day(s) on August 15, 2025. This event was a transfer of 56 contract(s) at a $50.00 strike. This particular put needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $40.8K, with a price of $730.0 per contract. There were 0 open contracts at this strike prior to today, and today 957 contract(s) were bought and sold. 
• For BA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), we notice a call option sweep that happens to be bullish, expiring in 22 day(s) on February 21, 2025. This event was a transfer of 73 contract(s) at a $175.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $51.1K, with a price of $700.0 per contract. There were 4829 open contracts at this strike prior to today, and today 579 contract(s) were bought and sold. 
• For LUNR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>), we notice a call option trade that happens to be neutral, expiring in 36 day(s) on March 7, 2025. This event was a transfer of 200 contract(s) at a $24.00 strike. The total cost received by the writing party (or parties) was $61.0K, with a price of $305.0 per contract. There were 91 open contracts at this strike prior to today, and today 571 contract(s) were bought and sold. 
• Regarding TTEK (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>), we observe a put option sweep with bearish sentiment. It expires in 50 day(s) on March 21, 2025. Parties traded 111 contract(s) at a $44.00 strike. This particular put needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $101.0K, with a price of $910.0 per contract. There were 440 open contracts at this strike prior to today, and today 425 contract(s) were bought and sold. 
• Regarding UPS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>), we observe a put option trade with bullish sentiment. It expires in 351 day(s) on January 16, 2026. Parties traded 100 contract(s) at a $115.00 strike. The total cost received by the writing party (or parties) was $144.0K, with a price of $1440.0 per contract. There were 1523 open contracts at this strike prior to today, and today 281 contract(s) were bought and sold. 
• For UPWK (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>), we notice a call option trade that happens to be bullish, expiring in 22 day(s) on February 21, 2025. This event was a transfer of 250 contract(s) at a $15.00 strike. The total cost received by the writing party (or parties) was $62.5K, with a price of $250.0 per contract. There were 2600 open contracts at this strike prior to today, and today 250 contract(s) were bought and sold. 
• For UNP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>), we notice a put option sweep that happens to be bullish, expiring in 351 day(s) on January 16, 2026. This event was a transfer of 25 contract(s) at a $230.00 strike. This particular put needed to be split into 25 different trades to become filled. The total cost received by the writing party (or parties) was $25.7K, with a price of $1030.0 per contract. There were 626 open contracts at this strike prior to today, and today 244 contract(s) were bought and sold. 
• Regarding GEV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>), we observe a call option trade with bullish sentiment. It expires in 22 day(s) on February 21, 2025. Parties traded 33 contract(s) at a $387.50 strike. The total cost received by the writing party (or parties) was $55.4K, with a price of $1680.0 per contract. There were 14 open contracts at this strike prior to today, and today 207 contract(s) were bought and sold. 
• Regarding SMR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>), we observe a call option sweep with bullish sentiment. It expires in 8 day(s) on February 7, 2025. Parties traded 100 contract(s) at a $20.00 strike. This particular call needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $41.9K, with a price of $420.0 per contract. There were 153 open contracts at this strike prior to today, and today 147 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

LUNR

TTEK

UBER

UPWK

10 Industrials Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Consumer Discretionary sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$400.00</td>
<td>$76.7K</td>
<td>13.4K</td>
<td>71.8K</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$90.00</td>
<td>$69.1K</td>
<td>12.0K</td>
<td>5.5K</td>
</tr>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$120.00</td>
<td>$36.9K</td>
<td>15.6K</td>
<td>4.8K</td>
</tr>
<tr>
<td>XPEV</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/07/25</td>
<td>$15.50</td>
<td>$97.6K</td>
<td>2.0K</td>
<td>2.0K</td>
</tr>
<tr>
<td>DECK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$235.00</td>
<td>$300.0K</td>
<td>169</td>
<td>1.5K</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$110.00</td>
<td>$32.6K</td>
<td>13.0K</td>
<td>1.1K</td>
</tr>
<tr>
<td>PTLO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$20.00</td>
<td>$148.0K</td>
<td>200</td>
<td>200</td>
</tr>
<tr>
<td>ABNB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$135.00</td>
<td>$26.8K</td>
<td>1.4K</td>
<td>103</td>
</tr>
<tr>
<td>AMZN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$225.00</td>
<td>$42.5K</td>
<td>1.6K</td>
<td>47</td>
</tr>
<tr>
<td>SIG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$60.00</td>
<td>$25.9K</td>
<td>230</td>
<td>37</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we observe a call option sweep with bullish sentiment. It expires in 1 day(s) on January 31, 2025. Parties traded 118 contract(s) at a $400.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $76.7K, with a price of $655.0 per contract. There were 13453 open contracts at this strike prior to today, and today 71837 contract(s) were bought and sold. 
• Regarding NKE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), we observe a call option sweep with bullish sentiment. It expires in 50 day(s) on March 21, 2025. Parties traded 973 contract(s) at a $90.00 strike. This particular call needed to be split into 63 different trades to become filled. The total cost received by the writing party (or parties) was $69.1K, with a price of $71.0 per contract. There were 12071 open contracts at this strike prior to today, and today 5555 contract(s) were bought and sold. 
• Regarding PDD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), we observe a call option trade with bearish sentiment. It expires in 22 day(s) on February 21, 2025. Parties traded 100 contract(s) at a $120.00 strike. The total cost received by the writing party (or parties) was $36.9K, with a price of $369.0 per contract. There were 15656 open contracts at this strike prior to today, and today 4807 contract(s) were bought and sold. 
• For XPEV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>), we notice a put option trade that happens to be neutral, expiring in 8 day(s) on February 7, 2025. This event was a transfer of 1952 contract(s) at a $15.50 strike. The total cost received by the writing party (or parties) was $97.6K, with a price of $50.0 per contract. There were 2008 open contracts at this strike prior to today, and today 2054 contract(s) were bought and sold. 
• Regarding DECK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>), we observe a call option trade with bearish sentiment. It expires in 1 day(s) on January 31, 2025. Parties traded 600 contract(s) at a $235.00 strike. The total cost received by the writing party (or parties) was $300.0K, with a price of $500.0 per contract. There were 169 open contracts at this strike prior to today, and today 1531 contract(s) were bought and sold. 
• For BABA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), we notice a call option trade that happens to be bullish, expiring in 141 day(s) on June 20, 2025. This event was a transfer of 40 contract(s) at a $110.00 strike. The total cost received by the writing party (or parties) was $32.6K, with a price of $815.0 per contract. There were 13012 open contracts at this strike prior to today, and today 1160 contract(s) were bought and sold. 
• Regarding PTLO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTLO#NASDAQ">PTLO</a>), we observe a put option trade with bearish sentiment. It expires in 715 day(s) on January 15, 2027. Parties traded 200 contract(s) at a $20.00 strike. The total cost received by the writing party (or parties) was $148.0K, with a price of $740.0 per contract. There were 200 open contracts at this strike prior to today, and today 200 contract(s) were bought and sold. 
• Regarding ABNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>), we observe a put option trade with bullish sentiment. It expires in 50 day(s) on March 21, 2025. Parties traded 29 contract(s) at a $135.00 strike. The total cost received by the writing party (or parties) was $26.8K, with a price of $925.0 per contract. There were 1497 open contracts at this strike prior to today, and today 103 contract(s) were bought and sold. 
• For AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we notice a put option trade that happens to be bullish, expiring in 106 day(s) on May 16, 2025. This event was a transfer of 39 contract(s) at a $225.00 strike. The total cost received by the writing party (or parties) was $42.5K, with a price of $1090.0 per contract. There were 1642 open contracts at this strike prior to today, and today 47 contract(s) were bought and sold. 
• For SIG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>), we notice a put option sweep that happens to be bearish, expiring in 169 day(s) on July 18, 2025. This event was a transfer of 32 contract(s) at a $60.00 strike. This particular put needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $25.9K, with a price of $810.0 per contract. There were 230 open contracts at this strike prior to today, and today 37 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABNB

AMZN

BABA

DECK

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PTLO

XPEV

10 Consumer Discretionary Stocks Whale Activity In Today's Session

Earnings

Small Cap

Press Releases

Newtopia Reports Fourth Quarter, Full Year 2023 and First Quarter 2024 Financial Results

NEWTOPIA CONFIRMS STRATEGIC ALTERNATIVE REVIEW PROCESS TO MAXIMIZE SHAREHOLDER VALUE, REINSTATEMENT OF TRADING AND PROVIDES CORPORATE UPDATE

Newtopia Schedules Second Quarter 2024 Earnings Release and Conference Call

Newtopia Reports Second Quarter 2024 Financial Results

NEWTOPIA ANNOUNCES BRIDGE LOAN FROM BLOOM BURTON & CO.

Newtopia Expands Proven GLP-1 Support Programs with Global Apparel Leader and Provides Update on its Strategic Process

Contracts

Newtopia Signs Framework Agreement with Supplemental Insurance Payvider to Offer its Proven Habit Change Platform to Thousands of U.S. Workers as a Fully-Covered Benefit

Newtopia Reports Third Quarter 2024 Financial Results

Newtopia

Photo by <a href="https://unsplash.com/photos/mNGaaLeWEp0">Emma Simpson</a> on<a href="https://unsplash.com/s/photos/health?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText"> Unsplash</a>

&nbsp;

The following post was written and/or published as a collaboration between Benzinga&rsquo;s in-house sponsored content team and a financial partner of Benzinga.

There&rsquo;s an old saying that goes, &ldquo;An ounce of prevention is worth a pound of cure,&rdquo; meaning it&rsquo;s easier to prevent something from happening in the first place than to try and fix it after the fact. That holds true for many things in life and is advice that can arguably be applied directly to one&rsquo;s own health and the health of businesses as well.&nbsp;

While this doesn&rsquo;t mean that every illness or ailment can be prevented, steps can be taken to change an individual&#39;s habits and give the human body and mind the best possible chance to stave off the progression of chronic conditions or even prevent their occurrence in the first place.

Knowing the proper steps to prevent, slow, and reverse chronic disease can overwhelm even the most health-conscious individuals. For that, a knowledgeable guide and toolkit of resources are invaluable to anyone willing to bring positive change to their lives. One of those resources is <a href="https://www.newtopia.com/">Newtopia</a> (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/NEWUF#OTCQB">NEWUF</a>) (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/NEWU#TSXV">NEWU</a>), a tech-enabled habit change provider.

<h2>The Whole Person Approach</h2>

Newtopia is unlike any other telehealth or habit change tool available on the market today. The company&rsquo;s one-size-fits-one whole-person approach focuses on the individual at risk, building that person&rsquo;s confidence, physical and mental wellbeing over time to develop long-term habit change. Newtopia&rsquo;s proven capabilities are evidence-based and grounded in science and have received full recognition from the Centers for Disease Control and Prevention.

Newtopia leverages the best of human &ndash; its health coaches or Inspirators &ndash; with the best of digital &ndash; its proprietary HIPAA-compliant technology platform and data analytics &ndash; to incrementally change habits around nutrition, exercise, and mental wellbeing. By leveraging the genetic profile of the individual, coupled with their social habits and behavioral insights, Newtopia develops a personalized prevention program for each participant that combines virtual care, digital tools, connected devices (wearables, digital scales), and actionable data science.&nbsp;

Newtopia&rsquo;s clients represent a substantial addressable market including self-insured employers (~140 million people), private insurers (~100 million people), and public health / government healthcare providers (~138 million people). The company&rsquo;s client portfolio includes very well-known brands such as CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), and Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>), who believe investing in their workers is essential to the long-term financial success of their companies.

Although Newtopia&rsquo;s focus has been on type 2 diabetes, heart disease, stroke, and obesity, the changes in habits that are suggested through the program can also have a positive impact on a person&rsquo;s mental health, soothe other chronic conditions, and improve overall resilience. This innovative whole-person approach &ndash; the concept that physical and mental wellbeing are linked &ndash; has arguably become even more important as a result of COVID-19.

<h2>How it Works</h2>

It all begins with meeting individuals at a point of concern with their health during the onboarding process. Using biometric testing and online health assessment tools, Newtopia identifies the risk eligibility of individuals. Candidates are then matched with an Inspirator and the right smart technology which together walks them through the recommended steps towards habit change - whether that be new exercise routines, dietary changes, or methods to improve and enhance mental health. Through virtual coaching sessions, simple tracking, gaming, and a curated social health community, participants work to meet incremental goals to change everyday habits and improve their overall health. By forming deep and lasting participant relationships, Newtopia is also able to offer curation of other available health benefits and deliver greater adherence to its program.

The ultimate goal is to lead each individual to a healthier place which could mean fewer trips to the doctor or emergency room, reduced reliance on medication, and more opportunities to enjoy life. Newtopia&rsquo;s platform not only improves health but also saves money for health insurers through reduced health insurance costs. For instance, a healthy individual incurs&nbsp;~$3,400 a year in medical expenses. With one or two risk factors such as elevated weight, blood pressure, or glucose, those expenses increase to $5,400 a year. Once someone reaches the chronic category, medical costs can be upwards of $15,000 to $20,000 or more. That is a massive unmanaged liability for health insurers.

<h2>A Win-Win Business Opportunity</h2>

Today 90% of America&rsquo;s $4.0 trillion of annual healthcare costs paid for by health insurers are attributed to individuals with chronic and mental health conditions. But, what if we could reduce this figure? Newtopia does just that by limiting healthcare costs for individuals, employers, and insurance providers. The cost savings positively impact all three groups. With the world still facing a massive pandemic, healthcare costs continue to skyrocket and the time to find ways to reduce such costs is now.&nbsp;&nbsp;

Newtopia&rsquo;s cost savings and return on investment to health insurers, including self-insured employers, private and government health plans, have been proven time and time again. In a randomized controlled trial conducted in conjunction with Aetna, Newtopia&rsquo;s program showed a yearly cost savings of just under $1,500 per employee. In another study conducted with Medicare Advantage participants, cost savings totaled $1,700 per individual per year. These findings demonstrate that if a company chooses to partner with Newtopia for its workforce as a benefit, it may be likely to result in a healthier employee or member population and drive significant savings.

Are you curious about how much <a href="https://investor.newtopia.com/overview/default.aspx">a company could save</a> by providing its employees the opportunity to improve their physical and mental health and decrease chronic disease occurrences? Use <a href="https://www.newtopia.com/b2b/">this calculator</a> to find out.

<h2>The Bigger Picture</h2>

As we continue to weather the global pandemic, we are seeing a considerable surge in the number of chronic disease cases, leaving health insurers and the insured to pick up the pieces. Newtopia is aiming to turn the healthcare industry on its side, to stop monetizing sickness and instead invest in long-term habit change.&nbsp; When people change their habits, they can change their lives and the lives of those around them. Coming together and taking a proactive approach to individuals&rsquo; health can have long-lasting benefits for all individuals and health insurers.&nbsp;

<h2>Opportunity to Learn More</h2>

Interested in learning more about Newtopia? Founder and CEO Jeff Ruby will be presenting next week at Benzinga&rsquo;s Healthcare Conference at 3:20 PM ET on Thursday, September 30th. Mr. Ruby will also be available to host investor meetings throughout the day. You can learn more about the event <a href="https://www.benzinga.com/events/small-cap/healthcare/">here</a>.&nbsp;

&nbsp;

The preceding post was written and/or published as a collaboration between Benzinga&rsquo;s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.

Comments

Newtopia

News

Latest news for Newtopia (OTC:NEWUF) Stock

Thursday, September 23, 2021

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga